
Corporate venture arm of a healthcare provider that backs early-stage healthcare technology companies

Israeli investor building agrifood technology and medical device companies from seed to market

The Trendlines Group invests in agrifood technology and medical technology, aiming to take innovations from seed to market. Its stated purpose is investing to improve the human condition. The global team brings together science, technology and business expertise, and the firm has offices in Misgav, Israel, and in Singapore.
Phytolon makes natural food colours derived from baker's yeast fermentation. The firm says its pigments offer value to consumers, to the environment and to the food industry. Its commercial and research relationships include an agreement with DSM, pilots with major food companies including Nestle, and a collaboration with Ginkgo Bioworks.
Vensica develops minimally invasive urology solutions that use therapeutic ultrasound to deliver neurotoxins, and it holds a strategic license and collaboration agreement with Merz Therapeutics. The FDA has cleared liberDi's digital dialysis system, and the firm says the product could become the standard of care for home peritoneal dialysis. Escala's product for pelvic organ prolapse is a minimally invasive, incision-free device, which the firm says could allow earlier treatment for millions of women.
AgroScout collects and analyzes data from fields, aircraft and satellites to produce reports on agricultural risks and sustainability. EcoPhage has received US EPA approval for its GoldenEco product and partnered with Dole to manage Moko disease in bananas. ElastiMed signed an exclusive US distribution agreement with Tactile Medical. The group's exits include ApiFix, which became a subsidiary of OrthoPediatrics in 2020, and OrthoSpin, which was acquired by Synthes in 2021.
Trendlines Group invests in and builds innovation-based companies in agrifood technology and medical technology. Its team combines science, technology and business skills to take ideas from seed to market. The firm states its purpose as investing to improve the human condition.
Summary written by TrustList from the business's own published information, Nov 2026.
2 images - click to enlarge
Used it? Your experience helps other buyers decide.
Write a reviewNo questions yet. Be the first to ask about Trendlines Group.
Similar listings buyers compare against this one.

Corporate venture arm of a healthcare provider that backs early-stage healthcare technology companies

Austin venture capital firm backing early-stage applied AI companies across North America

A venture capital firm and technology incubator backing science-led start-ups, led by two managing partners

Early-stage venture capital firm backing software-as-a-service and marketplace startups

Midwest venture capital firm investing in early-stage healthcare companies, from diagnostics to life science tools

Private investment firm running five strategies for growth, healthcare, mezzanine, holdings and franchise businesses

Angel investor group giving seed funding and management advice to climate technology startups

Chicago venture firm investing in blockchain and digital asset companies, with a crypto trading desk
Everything here links back to the same verified catalogue. Pick your next stop.